Healthcare | October 10, 2024
WHO declares India has eliminated Trachoma as a public health problem in 2024
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
CSPC will receive an upfront payment of $100 million from AstraZeneca
The company plans to advance Ropanicant into double-blind, placebo-controlled Phase-2b clinical study in MDD patients, anticipated to start in early 2025
The inspection conducted by EDQM at its Visakhapatnam facility
Gilead Sciences first launched Lenacapavir under the brand name Sunlenca in the United States and Europe markets in the year 2022
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
AMR poses a critical threat to global public health undermining decades of progress made in the field of modern medicine
The product is an additional formulation of Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg
Stable profits, low leverage to keep credit profiles comfortable
USFDA concludes inspection of Dr. Reddy's Laboratories R&D centre in Bachupally with zero observation
Subscribe To Our Newsletter & Stay Updated
